SOPH Q2 2021 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$305M

Q2 2021 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$10M+72.0% YoY

Gross Profit

$6M61.2% margin

Operating Income

-$16M-156.5% margin

Net Income

-$18M-180.7% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

+13.4%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$18M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$104M

Total Liabilities

$33M

Stockholders' Equity

$71M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$6M	+72.0%
Gross Profit	$6M	$4M	+57.1%
Operating Income	-$16M	-$7M	-126.2%
Net Income	-$18M	-$8M	-134.1%